anxiety. Generalized anxiety disorder
Conditions
Interventions
Intervention 1: Intervention group: : Midazolam .02mg / kg , One dose is injected as a premedication. Intervention 2: Intervention group: Midazolam .04mg / kg ,One dose is injected as a premedicat
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: 120 patients aged 20 to 60 years at risk of ASA1-2 undergoing non-emergency abdominal laparotomy undergoing GA at Rasool Akram Hospital
Exclusion criteria
Exclusion criteria: Patients with ASAIII risk The Pregnant patient Patients with psychiatric disorders or receiving sedative and antipsychotic medications Mental dysfunction Patients with visual or hearing impairment Patients with liver and kidney dysfunction Previous use of benzodiazepine
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Amnesia. Timepoint: Zero minutes (4 min before premedication), 2 (2 min before premedication), 4 (immediately before premedication) 6 min (2 min after premedication), 8 (4 min after Premedication) and 10 (6 min after premedication. Method of measurement: Cards with simple photos. | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood pressure. Timepoint: minutes 1,2,3 after intubation. Method of measurement: NIBP.;Heart rate. Timepoint: Minutes 1,2,5after intubation. Method of measurement: Monitoring device.;Decrease in oxygen saturation. Timepoint: Minutes 1,2,5after intubation. Method of measurement: Pulse oximetry. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAzadeh Habibi
Iran University of Medical Sciences
Outcome results
None listed